Mycobacteria library, 8/15
Bruker has announced what it says is a major expansion of its Mycobacteria Library for research use only on the MALDI Biotyper microbial mass spectrometry system.
Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace
Center for translational microbiology at ILSE, 8/15
The Institute for Life Science Entrepreneurship and ATCC will collaborate to establish the ATCC Center for Translational Microbiology at ILSE. The focus of the center will be on key challenges identified by both ATCC and ILSE in current translational microbiology, including antimicrobial resistance, synthetic biology, microbial bioinformatics, and the microbiome.
Microbiologics launches business solutions division, 8/15
Microbiologics has launched a Business Solutions division dedicated to partnering with diagnostic and life science technology manufacturers. Users of these instruments and assays need biological controls to meet regulatory requirements for validation, verification, and quality control.
Ultra-low attachment plate, 8/15
InSphero released its GravityTrap Ultra-low Attachment (ULA) Plate. The automation-compatible 96-well ULA format is well suited for production of 3-D tumor microtissues derived from tumor cell lines or to screen for the propensity of cells to form spheroids in a low-attachment environment.
Group B strep test receives 510(k) clearance, 8/15
Great Basin Scientific announced the FDA clearance and commercial availability of its molecular diagnostic test for group B streptococcus. The group B strep assay provides accurate results in approximately 90 minutes with a specimen from enriched LIM broth. By targeting a highly conserved region of the cfb (CAMP factor) gene, the molecular assay provides definitive identification and a more rapid diagnosis of the mother’s GBS colonization status compared to standard culture-based tests, which may take up to an additional 48 hours.
Transgenomic, Horizon OEM agreement, 8/15
Horizon Discovery Group and Transgenomic announced a new original equipment manufacturer agreement to incorporate Horizon’s human genomic reference standards, produced by Horizon’s diagnostics division, into Transgenomic’s Multiplexed ICE COLD-PCR (MX-ICP) kits for use in research and clinical applications. Further details of the agreement were not disclosed.
Flocked-swab patent, 8/15
Puritan Medical Products announced that its flocked swab products do not infringe on the intellectual property of Copan, according to a decision recently issued by the European Patent Office.
Glucose meter cleared for ICU, 8/15
The FDA has cleared Nova Biomedical’s StatStrip Xpress Glucose Hospital Meter System for use throughout all hospital and all professional health care settings, including among critically ill patients. StatStrip Glucose and StatStrip Xpress Glucose are, at press time, the only two hospital blood glucose meters to be cleared by the FDA for use with critically ill patients. StatStrip Xpress Glucose uses the same test strip measurement technology as StatStrip Glucose, which was cleared in 2014 after a four-year study conducted at five university medical centers.
Collaboration to develop cfDNA reference standards, 8/15
CareDx and Horizon Discovery Group will collaborate to develop cell-free DNA reference standards. The HDx Reference standards, being developed by Horizon Diagnostics, will support proficiency testing of CareDx’s solid organ transplant injury monitoring diagnostic tests and will be integrated into CLIA laboratory testing.
PerkinElmer, Covaris partnership, 8/15
PerkinElmer’s Chemagic research instrumentation and kits are now available with the Covaris TruXtrac FFPE DNA MicroTube Kit for Chemagen Technology for DNA/RNA purification powered by Adaptive Focused Acoustics technology. The kit rapidly removes paraffin and rehydrates formalin-fixed, paraffin-embedded tissues in an aqueous buffer. This preparation is optimized to work with PerkinElmer’s automated magnetic bead-based DNA/RNA separation technology for low-, medium-, and high-throughput solutions.